Eggehard Holler

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 12

Top Venues

Nanomedicine (London, England)

Nature communications

ACS nano

Cancer research

Cedars-Sinai Medical Center

Goethe-Universität Frankfurt am Main Institut für Physikalische und Theoretische Chemie (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Cedars-Sinai Medical Center Apr 01 2008

United States

Research Scientist III :: Neurosurgery

Institut fuer Biophysik und Physikalische Biochemie der Universitaet Regensburg

Germany

Professor fuer Biochemie :: Department Biologie und Vorklinik

Education History

Goethe-Universität Frankfurt am Main Institut für Physikalische und Theoretische Chemie

Germany

PHD :: Naturwissenschaften

Publications

Julia Y Ljubimova, Eggehard Holler, Keith L Black, Alexander V Ljubimov
Nanoparticles crossing blood-brain barrier need specific design for normal, neurodegenerative or cancerous brain conditions. Nanomedicine (London, England) (2024)
Julia Y Ljubimova, Eggehard Holler, Keith L Black, Alexander V Ljubimov
Nanoparticles crossing blood-brain barrier need specific design for normal, neurodegenerative or cancerous brain conditions. Nanomedicine (London, England) (2024)
Julia Y Ljubimova, Eggehard Holler, Keith L Black, Alexander V Ljubimov
Nanoparticles crossing blood-brain barrier need specific design for normal, neurodegenerative or cancerous brain conditions. Nanomedicine (London, England) (2024)
Julia Y Ljubimova, Eggehard Holler, Keith L Black, Alexander V Ljubimov
Nanoparticles crossing blood-brain barrier need specific design for normal, neurodegenerative or cancerous brain conditions. Nanomedicine (London, England) (2024)
Liron Limor Israel, Anna Galstyan, Alysia Cox, Ekaterina S Shatalova, Tao Sun, Mohammad-Harun Rashid, Zachary Grodzinski, Antonella Chiechi, Dieu-Trang Fuchs, Rameshwar Patil, Maya Koronyo-Hamaoui, Keith L Black, Julia Y Ljubimova, Eggehard Holler
Signature Effects of Vector-Guided Systemic Nano Bioconjugate Delivery Across Blood-Brain Barrier of Normal, Alzheimer's, and Tumor Mouse Models. ACS nano 16 (8) (2022)
Julia Y Ljubimova, Arshia Ramesh, Liron Limor Israel, Eggehard Holler
Small-Sized Co-Polymers for Targeted Delivery of Multiple Imaging and Therapeutic Agents. Nanomaterials (Basel, Switzerland) 11 (11) (2021)
Anna Galstyan, Janet L Markman, Ekaterina S Shatalova, Antonella Chiechi, Alan J Korman, Rameshwar Patil, Dmytro Klymyshyn, Warren G Tourtellotte, Liron L Israel, Oliver Braubach, Vladimir A Ljubimov, Leila A Mashouf, Arshia Ramesh, Zachary B Grodzinski, Manuel L Penichet, Keith L Black, Eggehard Holler, Tao Sun, Hui Ding, Alexander V Ljubimov, Julia Y Ljubimova
Author Correction: Blood-brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapy. Nature communications 11 (1) (2020)
Rameshwar Patil, Anna Galstyan, Zachary B Grodzinski, Ekaterina S Shatalova, Shawn Wagner, Liron Limor Israel, Hui Ding, Keith L Black, Julia Y Ljubimova, Eggehard Holler
Single- and Multi-Arm Gadolinium MRI Contrast Agents for Targeted Imaging of Glioblastoma. International journal of nanomedicine 15 (2020)
Anna Galstyan, Janet L Markman, Ekaterina S Shatalova, Antonella Chiechi, Alan J Korman, Rameshwar Patil, Dmytro Klymyshyn, Warren G Tourtellotte, Liron L Israel, Oliver Braubach, Vladimir A Ljubimov, Leila A Mashouf, Arshia Ramesh, Zachary B Grodzinski, Manuel L Penichet, Keith L Black, Eggehard Holler, Tao Sun, Hui Ding, Alexander V Ljubimov, Julia Y Ljubimova
Author Correction: Blood-brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapy. Nature communications 11 (1) (2020)
Anna Galstyan, Janet L Markman, Ekaterina S Shatalova, Antonella Chiechi, Alan J Korman, Rameshwar Patil, Dmytro Klymyshyn, Warren G Tourtellotte, Liron L Israel, Oliver Braubach, Vladimir A Ljubimov, Leila A Mashouf, Arshia Ramesh, Zachary B Grodzinski, Manuel L Penichet, Keith L Black, Eggehard Holler, Tao Sun, Hui Ding, Alexander V Ljubimov, Julia Y Ljubimova
Blood-brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapy. Nature communications 10 (1) (2019)
Tao Sun, Rameshwar Patil, Anna Galstyan, Dmytro Klymyshyn, Hui Ding, Alexandra Chesnokova, Webster K Cavenee, Frank B Furnari, Vladimir A Ljubimov, Ekaterina S Shatalova, Shawn Wagner, Debiao Li, Adam N Mamelak, Serguei I Bannykh, Chirag G Patil, Jeremy D Rudnick, Jethro Hu, Zachary B Grodzinski, Arthur Rekechenetskiy, Vida Falahatian, Alexander V Lyubimov, Yongmei L Chen, Lai Sum Leoh, Tracy R Daniels-Wells, Manuel L Penichet, Eggehard Holler, Alexander V Ljubimov, Keith L Black, Julia Y Ljubimova
Blockade of a Laminin-411-Notch Axis with CRISPR/Cas9 or a Nanobioconjugate Inhibits Glioblastoma Growth through Tumor-Microenvironment Cross-talk. Cancer research 79 (6) (2019)
Liron Limor Israel, Oliver Braubach, Anna Galstyan, Antonella Chiechi, Ekaterina S Shatalova, Zachary Grodzinski, Hui Ding, Keith L Black, Julia Y Ljubimova, Eggehard Holler
A Combination of Tri-Leucine and Angiopep-2 Drives a Polyanionic Polymalic Acid Nanodrug Platform Across the Blood-Brain Barrier. ACS nano 13 (2) (2019)

Eggehard Holler.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Eggehard Holler